Michael Lukesch has recently closed his first financing round for Valanx Biotech. He started right after graduating into his entrepreneurial journey and cleared many obstacles on the way with excellence.Valanx focuses on a novel approach for protein conjugation. Specific, fast, and cost-effective. The company is operating in lower Austria.In the most recent episode of beginner&apos;s mind, Michael talks about how he brought himself to leap into entrepreneurship, navigating the rollercoaster ride of building a startup, what he learned at top-notch incubation programs like Rebel Bio and early-stage conferences like Biovaria. More information at  Michael Lukesch (<a href='https://www.linkedin.com/in/michaellukesch/'>https://www.linkedin.com/in/michaellukesch/</a>) Valanx (<a href='http://valanx.bio'>valanx.bio</a>)    <a href='http://linktr.ee/soschner'>linktr.ee/soschner</a>    <a href='http://lifescienceget2gether.com'>lifescienceget2gether.com</a>    <a rel="payment" href="https://lsg2g.substack.com/subscribe?">Support the show</a> (https://lsg2g.substack.com/subscribe?)

#8: European Tech Hubs - a Panel Discussion at the Resi Conference

In the podcast and at our events, we share inspiring stories from investors, entrepreneurs, and experts in an easy-to-understand and inspiring way.The LSG2G Partners invite the listeners to learn with them from the best and brightest minds behind disruptive businesses, innovative investments, prolific social movements, and technologies powering game-changing innovation. In intimate conversations, the host deconstructs the stories and strategies that he believes will move markets, change systems, and shape our future.Join the LSG2G Community: https://lsg2g.substack.com/